The Recommendation No. 7 in drug therapy

The safety of Patient and errors reduction in drug treatment are a priority of health care system in Italy.
Studies worldwide show that the causes of errors in therapy involve different health operators in most of  processes of medication administration.
According to a research conducted in the United Kingdom improper use of drugs causes more than 50%  of the events recorded. An other study in the United States showed a failure of therapy in 5% of hospitalized patients in a year.

For this reason in 2008, the Italian Ministry of Health has issued the Recommendation No. 7 for the prevention of death, coma or severe damages arising from errors in drug therapy. And recently, in concert with SIFO (Italian Society of Hospital Pharmacy), it conducted for a second time a survey through a questionnaire distributed to local health authorities and hospitals to assess the current state of knowledge and application of the Recommendation.
The results of the survey conducted in 2011 and published last month show an appropriate level of disclosure/knowledge of the Recommendation; more than two-thirds of the sample has an ongoing activity to monitor the implementation thereof. In almost all the structures there is a referent for security in pharmacy and preventive actions have been initiated by the adoption of guidelines, recommendations, procedures and/or protocols for the prevention of errors in treatment, to facilitate monitoring in various stages of drug management.

Among the various actions suggested by the Ministry of Health there is the introduction of computer technology covering the entire course of patient care.
The hospitals that use APOTECAchemo within their own Pharmacies for the preparation of chemotherapeutic perfectly meet the Directive of the Recommendation No. 7. The system in fact, came from humancare research and forty years of experience in automation and measurement of Loccioni Group; it is fully automatic, can be integrated with software-prescription medication and allows the preparation of cytostatic drugs in absolute safety for the operators and for the patient

Facebook Twitter Plusone Linkedin